Anti-Ebola Neutralizing Antibodies
Invention type: Technology
/
Case number: #17334
Isolated monoclonal antibodies which bind to Ebola virus glycoprotein and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Researchers
Kannan Tharakaraman
/
Vidya Subramanian
/
Devin Quinlan
/
Ram Sasisekharan
Departments: School of Engineering
Technology Areas: Diagnostics: Assays / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living
-
antibodies that bind ebola glycoprotein and uses thereof
United States of America | Granted | 10,894,818
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.